Researchers at JAIST partnered with Daiichi Sankyo and the University of Tsukuba have unveiled an innovative cancer treatment using bacteria that operates independent of the immune system. This novel bacterial therapy marks a departure from conventional immunotherapeutics, offering a potential breakthrough for cancer patients unresponsive to immune-based treatments. The collaborative effort represents a pioneering step in developing alternative oncologic modalities that circumvent immune system involvement.